NUS — Nu Skin Enterprises, Inc.
Is NUS overbought or oversold? Here is the current MarketMoodz read.
Nu Skin Enterprises, Inc. (NUS) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $3.93. The rating moved from Strong Oversold to Oversold on November 10, 2026.
- Public ratingOversold (as of November 17, 2026)
- Last close$3.93
- Last changeMoved from Strong Oversold to Oversold on November 10, 2026
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
See all oversold Consumer Defensive stocks →
AI analysis
Nu Skin Enterprises, Inc. (NUS) is a legacy direct-sell personal-care and wellness company trading at a depressed absolute price, reflecting persistent execution and perception risks. The firm's strengths include a recognized brand and an international distributor footprint, but revenue and earnings are sensitive to distributor engagement, promotional intensity, and discretionary consumer spending. Near-term upside depends on successful product introductions, cost cuts and stabilization of distributor metrics; downside is driven by regulatory or reputational shocks, weakening cash flow or balance-sheet pressures. Given limited new filing and social-data signals in the provided packet, the outlook contains material uncertainty and favors monitoring of upcoming operational updates and cash-flow disclosures before adopting a more directional stance.
Key factors
- Established direct-selling brand with global distributor footprint and recurring product portfolio in personal care and wellness
- Low absolute share price implies market-implied concerns and thin margin for error; valuation appears depressed versus historical peers
- Revenue and earnings volatility tied to distributor counts, promotions and seasonal product cycles
- Potential near-term catalysts: new product rollouts, cost rationalization, and targeted market promotions that could stabilize top-line and margins
- Limited available social and EDGAR signal in the provided dataset increases uncertainty around recent corporate actions or balance-sheet changes
- Consumer discretionary sensitivity: sales depend on discretionary spend and channel health in key APAC and North American markets
Risks
- Regulatory and legal risk from multi-level marketing channel scrutiny or state/federal investigations
- Declining or demobilized distributor base leading to persistent revenue erosion
- Competitive pressure from larger, digitally native beauty/wellness brands and retail channels
- Liquidity and leverage risk if operating cash flow weakens (limited dataset to confirm present liquidity buffers)
- Reputational risk from adverse publicity or high-profile distributor disputes that can rapidly reduce consumer trust
- Macroeconomic downturn or consumer-spend pullback that disproportionately affects discretionary personal-care purchases
- Foreign exchange and execution risk across international markets and supply-chain disruptions that increase costs
See today's live rating, score and targets
Members see the live hourly rating for NUS — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.